← Back to catalogue

Endobon®

FDA UDI

Class II (US FDA UDI)

by Biomet 3i, Llc

Identity

Trade Name
ENDOBON® FDA UDI
Generic Name
Bone matrix implant, animal-derived, non-bioabsorbable FDA UDI
Device Name
ENDOBON® XENOGRAFT GRANULES LARGE PARTICLE 2.0ML FDA UDI
Model / Reference
ROXLG20 FDA UDI
Description
ENDOBON® XENOGRAFT GRANULES LARGE PARTICLE 2.0ML FDA UDI

Identifiers

Primary DI / UDI-DI
03599870097564 FDA UDI
FDA Product Code
LYC FDA UDI
GMDN Term
Bone matrix implant, animal-derived, non-bioabsorbable FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
872.3930 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 2 Milliliter FDA UDI

Category: Bone matrix implant, animal-derived, non-bioabsorbable

Endobon® by Biomet 3i, Llc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Bone matrix implant, animal-derived, non-bioabsorbable.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Biomet 3i, Llc

Sources (1)

  • FDA UDI 901ab616-6c22-42f9-9399-7cd19eaa43ad 35 fields · synced May 30, 2026